These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Perineural invasion and Gleason 7-10 tumors predict increased failure in prostate cancer patients with pretreatment PSA <10 ng/ml treated with conformal external beam radiation therapy. Anderson PR; Hanlon AL; Patchefsky A; Al-Saleem T; Hanks GE Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1087-92. PubMed ID: 9719119 [TBL] [Abstract][Full Text] [Related]
3. Outcome and predictive factors for patients with Gleason score 7 prostate carcinoma treated with three-dimensional conformal external beam radiation therapy. Anderson PR; Hanlon AL; Horwitz E; Pinover W; Hanks GE Cancer; 2000 Dec; 89(12):2565-9. PubMed ID: 11135217 [TBL] [Abstract][Full Text] [Related]
4. Early stage prostate cancer treated with radiation therapy: stratifying an intermediate risk group. Lattanzi JP; Hanlon AL; Hanks GE Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):569-73. PubMed ID: 9231681 [TBL] [Abstract][Full Text] [Related]
5. Salvage radiation for a rising PSA following radical prostatectomy. Maier J; Forman J; Tekyi-Mensah S; Bolton S; Patel R; Pontes JE Urol Oncol; 2004; 22(1):50-6. PubMed ID: 14969805 [TBL] [Abstract][Full Text] [Related]
6. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features. Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249 [TBL] [Abstract][Full Text] [Related]
7. Predicting the need for adjuvant systemic therapy in patients receiving postprostatectomy irradiation. Forman JD; Duclos M; Shamsa F; Pontes EJ Urology; 1996 Mar; 47(3):382-6. PubMed ID: 8633406 [TBL] [Abstract][Full Text] [Related]
8. Evidence of increased failure in the treatment of prostate carcinoma patients who have perineural invasion treated with three-dimensional conformal radiation therapy. Bonin SR; Hanlon AL; Lee WR; Movsas B; al-Saleem TI; Hanks GE Cancer; 1997 Jan; 79(1):75-80. PubMed ID: 8988729 [TBL] [Abstract][Full Text] [Related]
9. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer. Wong WW; Schild SE; Vora SA; Halyard MY Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):24-9. PubMed ID: 15337536 [TBL] [Abstract][Full Text] [Related]
10. Effect of higher radiation dose on biochemical control after radical prostatectomy for PT3N0 prostate cancer. Valicenti RK; Gomella LG; Ismail M; Mulholland SG; Petersen RO; Corn BW Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):501-6. PubMed ID: 9806507 [TBL] [Abstract][Full Text] [Related]
11. Dose response in prostate cancer with 8-12 years' follow-up. Hanks GE; Hanlon AL; Epstein B; Horwitz EM Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):427-35. PubMed ID: 12243818 [TBL] [Abstract][Full Text] [Related]
12. External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era. Pollack A; Smith LG; von Eschenbach AC Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):507-12. PubMed ID: 10974469 [TBL] [Abstract][Full Text] [Related]
13. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy. Kupelian PA; Katcher J; Levin HS; Klein EA Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811 [TBL] [Abstract][Full Text] [Related]
14. Treatment results of adjuvant radiotherapy and salvage radiotherapy after radical prostatectomy for prostate cancer. Wadasaki K; Kaneyasu Y; Kenjo M; Matsuura K; Murakami Y; Hashimoto Y; Ito K; Kiriu H; Ito A Int J Clin Oncol; 2007 Feb; 12(1):37-41. PubMed ID: 17380439 [TBL] [Abstract][Full Text] [Related]
15. Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions. Hanks GE; Hanlon AL; Schultheiss TE; Pinover WH; Movsas B; Epstein BE; Hunt MA Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):501-10. PubMed ID: 9635695 [TBL] [Abstract][Full Text] [Related]
16. Defining the optimal radiation dose with three-dimensional conformal radiation therapy for patients with nonmetastatic prostate carcinoma by using recursive partitioning techniques. Horwitz EM; Hanlon AL; Pinover WH; Anderson PR; Hanks GE Cancer; 2001 Sep; 92(5):1281-7. PubMed ID: 11571744 [TBL] [Abstract][Full Text] [Related]
17. Radiotherapy after radical prostatectomy: does transient androgen suppression improve outcomes? King CR; Presti JC; Gill H; Brooks J; Hancock SL Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):341-7. PubMed ID: 15145146 [TBL] [Abstract][Full Text] [Related]
18. Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy. Zelefsky MJ; Aschkenasy E; Kelsen S; Leibel SA Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):327-33. PubMed ID: 9308935 [TBL] [Abstract][Full Text] [Related]
19. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores. Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457 [TBL] [Abstract][Full Text] [Related]